BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27248517)

  • 1. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.
    Noordam R; Avery CL; Visser LE; Stricker BH
    Pharmacogenomics; 2016 Jun; 17(9):1029-40. PubMed ID: 27248517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genetic loci associated with antidepressant drug response with drug-gene interaction models in a population-based study.
    Noordam R; Direk N; Sitlani CM; Aarts N; Tiemeier H; Hofman A; Uitterlinden AG; Psaty BM; Stricker BH; Visser LE
    J Psychiatr Res; 2015 Mar; 62():31-7. PubMed ID: 25649181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics with antidepressants in the STAR*D study.
    Lin E; Chen PS
    Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
    Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
    Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; CalabrĂ² M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in major depressive disorder: From pathophysiology to therapy.
    Gonda X; Petschner P; Eszlari N; Baksa D; Edes A; Antal P; Juhasz G; Bagdy G
    Pharmacol Ther; 2019 Feb; 194():22-43. PubMed ID: 30189291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
    Fabbri C; Serretti A
    Neurosci Lett; 2020 May; 726():133651. PubMed ID: 29906483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Tsai SJ; Hong CJ; Liou YJ
    Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder.
    Ahmed AT; Weinshilboum R; Frye MA
    Clin Pharmacol Ther; 2018 May; 103(5):767-769. PubMed ID: 29388201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for personalization of depression treatment with genome sequencing.
    Borczyk M; Piechota M; Rodriguez Parkitna J; Korostynski M
    Br J Pharmacol; 2022 Sep; 179(17):4220-4232. PubMed ID: 33786859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant pharmacogenetics.
    Singh AB; Bousman CA; Ng C; Berk M
    Curr Opin Psychiatry; 2014 Jan; 27(1):43-51. PubMed ID: 24270480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and Pharmacogenetics.
    Ampong DN
    Arch Psychiatr Nurs; 2018 Feb; 32(1):71-74. PubMed ID: 29413077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
    Peterson K; Dieperink E; Anderson J; Boundy E; Ferguson L; Helfand M
    Psychopharmacology (Berl); 2017 Jun; 234(11):1649-1661. PubMed ID: 28456840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.